A composite score to predict short-term disease activity in patients with relapsing-remitting MS
In the article “A composite score to predict short-term disease activity in patients with relapsing-remitting MS” by M.P. Sormani et al. (Neurology 2007;69:1230–1235), there is a discrepancy between the data in the text and the data in table 2. The hazard ratios (HRs) of prior 2-year relapses and Gd-enhancing lesions are reversed in the text compared to those reported in table 2 (page 1232: table 2 and Results section). The correct values are those reported in table 2. Therefore, the second sentence in the Results section should be changed to the following: “The variables included in the final model as independent predictors of relapse occurrence were the number of enhancing lesions (HR = 1.03, 95% CI = 1.02 to 1.05, p < 0.001) and the number of relapses during the previous 2 years (HR = 1.22, 95% CI = 1.11 to 1.33, p < 0.001).” The authors regret the error.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
A composite score to predict short-term disease activity in patients with relapsing-remitting MS
Oral contraceptives combined with interferon β in multiple sclerosis
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis